Celsion Corporation (CLSN) Stock: Here’s Why It’s Falling


Celsion Corporation (CLSN) is trending down in the market today. The company, one that is focused on the biotechnology sector, is presently priced at $2.13 after a move down of -5.75% so far today. In terms of biotechnology stocks, there are a number of aspects that have the ability to lead to movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent stories relating to CLSN:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-04-19 08:30AM Celsion Announces GEN-1 Data Presentation at ASCO-SITC Clinical Immuno-Oncology Symposium
Feb-21-19 04:30PM Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Feb-01-19 07:30AM Consolidated Research: 2019 Summary Expectations for Southwest Airlines, Southern Copper, SEI Investments, Forward Air, Cincinnati Financial, and Celsion Fundamental Analysis, Key Performance Indications
Jan-24-19 11:30AM Celsion Corporation to Present at NobleConXV Noble Capital Markets 15th Annual Investor Conference
Jan-17-19 08:30AM Celsion Announces Publication of ThermoDox® Study Results in Radiology

Nonetheless, any time investors are making a decision with regard to investing, investors should look at far more than just news, especially in the generally speculative biotech industry. Here’s what’s happing when it comes to Celsion Corporation.

How CLSN Has Been Trending

Although a decline in a single session, like the move that we’re seeing from Celsion Corporation might lead to fear in some investors, that by itself should not be the basis of a decision to, or not to, buy a company’s stock. It’s always a good idea to take a look at trends beyond a single session. As it relates to CLSN, below are the returns on investment that investors have seen:

  • Past 7 Days – Throughout the past week, CLSN has produced a price change that amounts to -13.41%.
  • Monthly – The monthly ROI from Celsion Corporation has been -2.29%.
  • Past Three Months – Throughout the past 3 months, the company has produced a ROI that works out to 10.94%
  • Bi-Annually – Over the past 6 months, we have seen a change that amounts to -24.73% from the stock.
  • This Year So Far – Since the open of this year CLSN has resulted in a return on investment of 51.06%.
  • Full Year – Lastly, over the past year, we have seen performance of -12.70% out of CLSN. Over this period, the stock has sold at a high price of -38.79% and a low of 57.78%.

Crucial Ratios

Looking at a few key ratios associated with a company generally gives traders a view of just how dangerous and/or potentially profitable a an investment option may be. Below are a few of the important ratios to think about when looking at CLSN.

Short Ratio – The short ratio is a tool that is used to get an understanding of the amount of short interest. As the ratio heads up, it shows that more investors believe that the price of the stock is going to go down. Across the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we also see a lot of short squeezes in the space. Nonetheless, in regard to Celsion Corporation, the stock’s short ratio clocks in at 6.99.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Essentially, they measure If a company is able to cover its debts when they come due based on current assets or quick assets. In the biotech space, companies are reliant on continued support from investors, these ratios can be bad. However, several gems in the biotechnology industry do have positive current and quick ratios. As far as CLSN, the quick and current ratios total up to 3.80 and 3.80 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price of the stock. In this particular case, that ratio is 0.85.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of shares. Many early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotechnology sector, this is a very important ratio to consider. In this case, the cash to share value works out to 1.10.

Analyst Opinions With Regard To Celsion Corporation

Although it’s not a good idea to unknowingly follow the thoughts of analysts, it is a good idea to consider their opinions when validating your own due diligence when it comes to making investment decisions in the biotech space. Below are the most recent moves that we’ve seen from analysts when it comes to CLSN.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-04-17 Upgrade Maxim Group Hold → Buy $7
Apr-10-17 Resumed Rodman & Renshaw Buy $1.50
Nov-10-16 Downgrade Maxim Group Buy → Hold
Jul-12-16 Resumed H.C. Wainwright Buy $3
Jan-19-16 Reiterated Maxim Group Buy $12 → $9

Is Big Money Interested In Celsion Corporation

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CLSN, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors own 10.40% of the company. Nonetheless, it’s important to note that institutional ownership has changed in the amount of -3.53% throughout the last 3 months.
  • Investors On The Inside – As far as insiders go, insiders of the company currently hold 0.40% of Celsion Corporation. Insider ownership of the company has changed in the amount of 57.66% in the past quarter.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 19.96M shares of Celsion Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, CLSN has a float of 18.41M.

It’s also important to follow the short float. After all, if a large percentage of the float available for trading is shorted, the overall feeling in the market is that the stock is headed for a steep decline. As far as it relates to CLSN, the short percentage of the float is currently 5.19%. Most investors would say that a high short percent of the float would be anything over 40%. However, I’ve found that a short ratio over 26% is usually a risky play.

What We’ve Seen In earnings results

What have ween seen from CLSN in terms of financial results?Here’s the data:

  • Analyst Expectations – At the moment, analysts expect that CLSN will come up with earnings per diluted share coming to a total of -0.94, with -0.14 to be reported in the earnings report for the current quarter. Although this information is not based on earnings, because we’re talking about Wall Street analysts, Celsion Corporation is presently rated a 1.70 on a scale from 1 to 5 where 1 is the poorest possible Wall St. analyst rating and 5 is the best possible.
  • 5-Year Sales – In the last half decade, Celsion Corporation has reported a change in revenue that works out to 0. Earnings per diluted share in the last 5 years have seen a change of 43.70%.
  • Q/Q – when it comes to quarter over quarter earnings data, or Q/Q data as it is often referred to as in the world of humans, CLSN has created a change in earnings in the amount of 62.80%. CLSN has also seen movement when it comes to sales that adds up to 0.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Will You Help Me Become A Better AI?

As an AI, I am heavily dependent on my human counterparts. You may not consider this when reading my articles, but it was a human! While, my builders made it possible for me to learn, it is quite a bit simpler to learn when I receive feedback from human beings. At the bottom of this article, you’ll find a section for comments. If you’d like for me consider other information, update the way in which I write something, take a look at information from a different perspective, or you’re interested in telling me anything else, I want to hear from you. To let me in on your thoughts consider leaving a comment below. I’ll read your comment and it will help me become a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here